Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS): A multicenter study

被引：0
|
作者：
Alshibany, Aisha
Zhou, Maggie
Warren, Emilie Ak
Ganjoo, Kristen N.
Demicco, Elizabeth
Feeney, Jordan
Lee, Jasmine
Shultz, David Benjamin
Spickard, Erik
Bui, Nam
Cardona, Kenneth
Salawu, Abdulazeez
Razak, Albiruni Ryan Abdul
机构：
[1] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Stanford Univ, Med Ctr, Stanford, CA USA
[3] Emory Univ, Winship Canc Inst, Div Surg Oncol, Dept Surg, Atlanta, GA USA
[4] Stanford Canc Inst, Stanford, CA USA
[5] Mt Sinai Hosp, Toronto, ON, Canada
[6] Natera Inc, Austin, TX USA
[7] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[8] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[9] Stanford Univ, Stanford, CA USA
[10] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[11] Univ Toronto, Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11537
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS)
    Salawu, Abdulazeez
    Demicco, Elizabeth
    Chung, Peter W. M.
    Feeney, Jordan
    Spickard, Erik
    Rathore, Richa
    Lee, Jasmine
    Wong, Philip
    Malone, Eoghan Ruadh
    Catton, Charles
    Arones, Limore
    Phillips, Madeline J.
    Ferguson, Peter Charles
    Wunder, Jay
    Tin, Tony
    Sethi, Himanshu
    Liu, Minetta C.
    Shultz, David Benjamin
    Razak, Albiruni Ryan Abdul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Circulating tumor DNA (ctDNA) detection of molecular residual disease (MRD) as a potential biomarker in localized soft tissue sarcoma (STS).
    Salawu, Abdulazeez
    Demicco, Elizabeth
    Chung, Peter W. M.
    Feeney, Jordan
    Lee, Jasmine
    Malone, Eoghan Ruadh
    Catton, Charles
    Arones, Limore
    Phillips, Madeline J.
    Wong, Philip
    Wunder, Jay
    Ferguson, Peter Charles
    Willingham, Stephen
    Shultz, David Benjamin
    Razak, Albiruni Ryan Abdul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
    Re-I Chin
    Kevin Chen
    Abul Usmani
    Chanelle Chua
    Peter K. Harris
    Michael S. Binkley
    Tej D. Azad
    Jonathan C. Dudley
    Aadel A. Chaudhuri
    [J]. Molecular Diagnosis & Therapy, 2019, 23 : 311 - 331
  • [4] Detection of Solid Tumor Molecular Residual Disease(MRD) Using Circulating Tumor DNA (ctDNA)
    Chin, Re-I
    Chen, Kevin
    Usmani, Abul
    Chua, Chanelle
    Harris, Peter K.
    Binkley, Michael S.
    Azad, Tej D.
    Dudley, Jonathan C.
    Chaudhuri, Aadel A.
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (03) : 311 - 331
  • [5] Enhanced detection of molecular residual disease (MRD) by tumor-informed and tumor-agnostic variants in circulating tumor DNA (ctDNA)
    Yan, Xiaoluan
    Li, Zhencong
    Wang, YanYan
    Li, Juan
    Liu, Ming
    Wang, Hongwei
    Jin, Kemin
    Bao, Quan
    Wang, Lijun
    Liu, Wei
    Liu, Lijuan
    Da, Xu
    Hu, Yifan
    Zhang, Yiqun
    Zang, Yuehua
    Pei, Zhihua
    Wang, Dongliang
    Zhou, Qiming
    Xing, Baocai
    Wang, Kun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Circulating tumor DNA (ctDNA) for detection of molecular residual disease (MoRD) in breast cancer
    Austin, L.
    Jaslow, R.
    Fortina, P.
    Nagy, R.
    Zill, O.
    Talasaz, A.
    Cristofanilli, M.
    [J]. CANCER RESEARCH, 2016, 76
  • [7] Development of Circulating Tumor DNA (ctDNA) for Molecular Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
    Gunaratne, Ruwan
    Zhou, Crystal
    Tai, Jesse W.
    Schwede, Matthew
    Tanaka, Kailee
    Alkaitis, Matthew
    Yin, Raymond
    Sworder, Brian J.
    Mannis, Gabriel
    Majeti, Ravindra
    Khodadoust, Michael S.
    Kurtz, David M.
    Zhang, Tian Y.
    [J]. BLOOD, 2023, 142
  • [8] Minimal residual disease (MRD) detection with circulating tumor DNA (ctDNA) from personalized assays in stage II-III colorectal cancer patients in a UK multicenter prospective study (TRACC)
    Anandappa, Gayathri
    Starling, Naureen
    Begum, Ruwaida
    Bryant, Annette
    Sharma, Shruti
    Renner, Derrick
    Aresu, Maria
    Peckitt, Clare
    Sethi, Himanshu
    Feber, Andrew
    Potter, Vanessa Alice
    Paraoan, Marius
    Abulafi, Muti
    George, Nicol
    Branagan, Graham
    Duff, Sarah
    West, Nicholas
    Aleshin, Alexey
    Chau, Ian
    Cunningham, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [9] A clinical validation study to predict recurrence in stage II-III colorectal cancer (CRC) using a bespoke circulating tumor DNA (ctDNA) assay to detect molecular residual disease (MRD): The CORRECT-MRD I study
    Srinivasan, G.
    Hubert, A.
    Purim, O.
    Semenisty, V.
    Lo, N.
    Tsukada, Y.
    Mondello, G.
    Cubillo, A.
    Subramaniam, S.
    Palomares, M. R.
    Baehner, R. F. L.
    De Jong, F.
    Kerr, D. J.
    Yoshino, T.
    [J]. ANNALS OF ONCOLOGY, 2024, 35 : S69 - S70
  • [10] Utility of circulating tumor DNA (ctDNA) for detection of minimal residual disease (MRD) after curative-intent therapy in localized pancreatic cancer (PDAC)
    Yanala, Ujwal R.
    Martos, Mary
    Dickey, Erin M.
    Corona, Andres
    Ezenwajiaku, Nkiruka
    Pizzolato, Joseph
    Terrero, Gretel
    Hester, Caitlin A.
    Merchant, Nipun
    Hosein, Peter
    Datta, Jash
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S23 - S24
12345